Dexamethasone-mediated activation of fibronectin matrix assembly reduces dispersal of primary human glioblastoma cells

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Shannon, Stephen ^a   Vaca, Connan ^a   Jia, Dongxuan ^a   Entersz, Ildiko ^a   Schaer, Andrew ^a   Carcione, Jonathan ^a   Weaver, Michael ^a   Avidar, Yoav ^a   Pettit, Ryan ^a   Nair, Mohan ^a   Khan, Atif ^a   Foty, Ramsey A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FIBRONECTIN; MIFEPRISTONE; ANTIINFLAMMATORY AGENT; MESSENGER RNA; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL GROWTH; CELL ISOLATION; CELL MOTILITY; EX VIVO STUDY; FIBRONECTIN MATRIX ASSEMBLY; GLIOBLASTOMA; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TISSUE MICROARRAY; TUMOR CELL; BRAIN NEOPLASMS; CELL AGGREGATION; EXTRACELLULAR MATRIX; GENETICS; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR INVASION;

ANTI-INFLAMMATORY AGENTS; BRAIN NEOPLASMS; CELL ADHESION; CELL AGGREGATION; DEXAMETHASONE; EXTRACELLULAR MATRIX; FIBRONECTINS; GLIOBLASTOMA; HUMANS; INTEGRIN ALPHA5BETA1; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84942509143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135951     Document Type: Article

References (50)

1. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet Oncology. 2009; 10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7 PMID: 19269895.
2. Sampetrean O, Saga I, Nakanishi M, Sugihara E, Fukaya R, Onishi N, et al. Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells. Neoplasia. 2011; 13(9):784-91. PMID: 21969812; PubMed Central PMCID: PMC3182271.
3. Clarke J, Butowski N, Chang S. Recent advances in therapy for glioblastoma. Archives of neurology. 2010; 67(3):279-83. Epub 2010/03/10. doi: 10.1001/archneurol.2010.5 PMID: 20212224.
4. Sabari J, Lax D, Connors D, Brotman I, Mindrebo E, Butler C, et al. Fibronectin matrix assembly suppresses dispersal of glioblastoma cells. PloS one. 2011; 6(9):e24810. Epub 2011/10/08. doi: 10.1371/journal.pone.0024810 PMID: 21980357; PubMed Central PMCID: PMC3184095.
5. Ryan PL, Foty RA, Kohn J, Steinberg MS. Tissue spreading on implantable substrates is a competitive outcome of cell-cell vs. cell-substratum adhesivity. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(8):4323-7. Epub 2001/03/29. PMID: 11274361; PubMed Central PMCID: PMC31833.
6. Garzon-Muvdi T, Schiapparelli P, ap Rhys C, Guerrero-Cazares H, Smith C, Kim DH, et al. Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation. PLoS biology. 2012; 10(5):e1001320. doi: 10.1371/journal.pbio.1001320 PMID: 22570591; PubMed Central PMCID: PMC3341330.
7. Davidson PM, Denais C, Bakshi MC, Lammerding J. Nuclear deformability constitutes a rate-limiting step during cell migration in 3-D environments. Cellular and molecular bioengineering. 2014; 7(3):293-306. doi: 10.1007/s12195-014-0342-y PMID: 25436017; PubMed Central PMCID: PMC4243304.
8. Kim SN, Jeibmann A, Halama K, Witte HT, Walte M, Matzat T, et al. ECM stiffness regulates glial migration in Drosophila and mammalian glioma models. Development. 2014; 141(16):3233-42. doi: 10.1242/dev.106039 PMID: 25063458.
9. Sechler JL, Takada Y, Schwarzbauer JE. Altered rate of fibronectin matrix assembly by deletion of the first type III repeats. The Journal of cell biology. 1996; 134(2):573-83. PMID: 8707839
10. Jia D, Entersz I, Butler C, Foty RA. Fibronectin matrix-mediated cohesion suppresses invasion of prostate cancer cells. BMC cancer. 2012; 12:94. Epub 2012/03/22. doi: 10.1186/1471-2407-12-94 PMID: 22433434; PubMed Central PMCID: PMC3359283.
11. Riemenschneider MJ, Mueller W, Betensky RA, Mohapatra G, Louis DN. In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation. The American journal of pathology. 2005; 167(5):1379-87. Epub 2005/10/28. doi: 10.1016/S0002-9440(10)61225-4 PMID: 16251422; PubMed Central PMCID: PMC1603783.
12. Haugland HK, Tysnes BB, Tysnes OB. Adhesion and migration of human glioma cells are differently dependent on extracellular matrix molecules. Anticancer research. 1997; 17(2A):1035-42. PMID: 9137446.
13. Paulus W, Tonn JC. Basement membrane invasion of glioma cells mediated by integrin receptors. Journal of neurosurgery. 1994; 80(3):515-9. doi: 10.3171/jns.1994.80.3.0515 PMID: 8113864.
14. Uhm JH, Gladson CL, Rao JS. The role of integrins in the malignant phenotype of gliomas. Frontiers in bioscience: a journal and virtual library. 1999; 4:D188-99. PMID: 9989953.
15. Kawataki T, Yamane T, Naganuma H, Rousselle P, Anduren I, Tryggvason K, et al. Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: Evidence for a role of alpha5-laminin(s) and alpha3beta1 integrin. Experimental cell research. 2007; 313(18):3819-31. PMID: 17888902.
16. Robinson EE, Foty RA, Corbett SA. Fibronectin matrix assembly regulates alpha5beta1-mediated cell cohesion. Molecular biology of the cell. 2004; 15(3):973-81. Epub 2004/01/14. PMID: 14718567; PubMed Central PMCID: PMC363054.
17. Mehta M, Khan A, Danish S, Haffty BG, Sabaawy HE. Radiosensitization of Primary Human Glioblastoma Stem-like Cells With Low-dose AKT Inhibition. Mol Cancer Ther 101158/1535-7163MCT-14-0708. 2015. doi: 10.1158/1535-7163.MCT-14-0708 PMID: 25695954.
18. Donev K, Scheithauer BW, Rodriguez FJ, Jenkins S. Expression of diagnostic neuronal markers and outcome in glioblastoma. Neuropathology and applied neurobiology. 2010; 36(5):411-21. doi: 10.1111/j.1365-2990.2010.01078.x PMID: 20298476.
19. Metcalfe P. Prediction of Pharmacokinetic profile for dexamethasone after oral and intravenous administratio to humans. Cyprotex Discover Limited, 2011.
20. Tomasini-Johansson BR, Kaufman NR, Ensenberger MG, Ozeri V, Hanski E, Mosher DF. A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly. The Journal of biological chemistry. 2001; 276(26):23430-9. Epub 2001/04/27. doi: 10.1074/jbc.M103467200 PMID: 11323441.
21. Maurer LM, Tomasini-Johansson BR, Ma W, Annis DS, Eickstaedt NL, Ensenberger MG, et al. Extended binding site on fibronectin for the functional upstream domain of protein F1 of Streptococcus pyogenes. The Journal of biological chemistry. 2010; 285(52):41087-99. doi: 10.1074/jbc.M110.153692 PMID: 20947497; PubMed Central PMCID: PMC3003407.
22. Chiang HY, Korshunov VA, Serour A, Shi F, Sottile J. Fibronectin is an important regulator of flow-induced vascular remodeling. Arteriosclerosis, thrombosis, and vascular biology. 2009; 29(7):1074-9. doi: 10.1161/ATVBAHA.108.181081 PMID: 19407246; PubMed Central PMCID: PMC3091823.
23. Butler CM, Foty RA. Measurement of aggregate cohesion by tissue surface tensiometry. Journal of visualized experiments: JoVE. 2011;(50: ). Epub 2011/04/21. doi: 10.3791/2739 PMID: 21505411; PubMed Central PMCID: PMC3169255.
24. Foty R, Steinberg M. Model systems displaying differential adhesion. WIRES Dev Biol. 2013.
25. Foty RA, Forgacs G, Pfleger CM, Steinberg MS. Liquid properties of embryonic tissues: Measurement of interfacial tensions. Physical review letters. 1994; 72(14):2298-301. PMID: 10055839.
26. Foty RA, Pfleger CM, Forgacs G, Steinberg MS. Surface tensions of embryonic tissues predict their mutual envelopment behavior. Development. 1996; 122(5):1611-20. Epub 1996/05/01. PMID: 8625847.
27. Windler-Hart SL, Chen KY, Chenn A. A cell behavior screen: identification, sorting, and enrichment of cells based on motility. BMC cell biology. 2005; 6(1):14. Epub 2005/03/24. doi: 10.1186/1471-2121-6-14 PMID: 15784137; PubMed Central PMCID: PMC1079802.
28. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer cell. 2010; 17(1):98-110. Epub 2010/02/05. doi: 10.1016/j.ccr.2009.12.020 PMID: 20129251; PubMed Central PMCID: PMC2818769.
29. Shen R, Mo Q, Schultz N, Seshan VE, Olshen AB, Huse J, et al. Integrative subtype discovery in glioblastoma using iCluster. PloS one. 2012; 7(4):e35236. Epub 2012/04/28. doi: 10.1371/journal.pone.0035236 PMID: 22539962; PubMed Central PMCID: PMC3335101.
30. Galante LL, Schwarzbauer JE. Requirements for sulfate transport and the diastrophic dysplasia sulfate transporter in fibronectin matrix assembly. The Journal of cell biology. 2007; 179(5):999-1009. Epub 2007/12/07. doi: 10.1083/jcb.200707150 PMID: 18056413; PubMed Central PMCID: PMC2099202.
31. Winters BS, Shepard SR, Foty RA. Biophysical measurement of brain tumor cohesion. International journal of cancer Journal international du cancer. 2005; 114(3):371-9. Epub 2004/11/20. doi: 10.1002/ijc.20722 PMID: 15551307.
32. Caicedo-Carvajal CE, Shinbrot T, Foty RA. Alpha5beta1 integrin-fibronectin interactions specify liquid to solid phase transition of 3D cellular aggregates. PloS one. 2010; 5(7):e11830. doi: 10.1371/journal.pone.0011830 PMID: 20686611; PubMed Central PMCID: PMC2912296.
33. Hynes RO. Fibronectins. Scientific American. 1986; 254(6):42-51. PMID: 3010451.
34. Hyder CL, Lazaro G, Pylvanainen JW, Roberts MW, Qvarnstrom SM, Eriksson JE. Nestin regulates prostate cancer cell invasion by influencing the localisation and functions of FAK and integrins. Journal of cell science. 2014; 127(Pt 10):2161-73. doi: 10.1242/jcs.125062 PMID: 24610946.
35. Nackman GB, Fillinger MF, Shafritz R, Wei T, Graham AM. Flow modulates endothelial regulation of smooth muscle cell proliferation: a new model. Surgery. 1998; 124(2):353-60; discussion 60-1. Epub 1998/08/26. PMID: 9706159.
36. Abercrombie M. Contact inhibition and malignancy. Nature. 1979; 281(5729):259-62. Epub 1979/09/27. PMID: 551275.
37. Martz E, Steinberg MS. The role of cell-cell contact in "contact" inhibition of cell division: a review and new evidence. Journal of cellular physiology. 1972; 79(2):189-210. Epub 1972/04/01. PMID: 5063615.
38. Nelson PJ, Daniel TO. Emerging targets: molecular mechanisms of cell contact-mediated growth control. Kidney international. 2002; 61(1 Suppl):S99-105. Epub 2002/02/14. doi: 10.1046/j.1523-1755.2002.0610s1099.x PMID: 11841621.
39. Serres E, Debarbieux F, Stanchi F, Maggiorella L, Grall D, Turchi L, et al. Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice. Oncogene. 2014; 33(26):3451-62. doi: 10.1038/onc.2013.305 PMID: 23912459.
40. Aaberg-Jessen C, Norregaard A, Christensen K, Pedersen CB, Andersen C, Kristensen BW. Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures. International journal of clinical and experimental pathology. 2013; 6(4):546-60. PMID: 23573302; PubMed Central PMCID: PMC3606845.
41. Jurado C, Haserick JR, Lee J. Slipping or gripping? Fluorescent speckle microscopy in fish keratocytes reveals two different mechanisms for generating a retrograde flow of actin. Molecular biology of the cell. 2005; 16(2):507-18. PMID: 15548591; PubMed Central PMCID: PMC545886.
42. Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer research. 2005; 65(11):4645-52. PMID: 15930282.
43. Douezan S, Guevorkian K, Naouar R, Dufour S, Cuvelier D, Brochard-Wyart F. Spreading dynamics and wetting transition of cellular aggregates. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(18):7315-20. Epub 2011/04/21. doi: 10.1073/pnas.1018057108 PMID: 21504944; PubMed Central PMCID: PMC3088609.
44. Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nature cell biology. 2007; 9(8):893-904. Epub 2007/07/10. PMID: 17618273.
45. Wolf K, Muller R, Borgmann S, Brocker EB, Friedl P. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood. 2003; 102(9):3262-9. doi: 10.1182/blood-2002-12-3791 PMID: 12855577.
46. Vizirianakis IS, Chen YQ, Kantak SS, Tsiftsoglou AS, Kramer RH. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells. International journal of oncology. 2002; 21(1):135-44. PMID: 12063560.
47. Leiguarda R, Sierra J, Pardal C, Zambrano D. Effect of large doses of methylprednisolone on supratentorial intracranial tumors. A clinical and CAT scan evaluation. European neurology. 1985; 24(1):23-32. Epub 1985/01/01. PMID: 3881262.
48. Hatam A, Bergstrom M, Yu ZY, Granholm L, Berggren BM. Effect of dexamethasone treatment on volume and contrast enhancement of intracranial neoplasms. Journal of computer assisted tomography. 1983; 7(2):295-300. Epub 1983/04/01. PMID: 6833563.
49. Vecht CJ, Hovestadt A, Verbiest HB, van Vliet JJ, van Putten WL. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology. 1994; 44(4):675-80. Epub 1994/04/01. PMID: 8164824.
50. McKeon RJ, Hoke A, Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Experimental neurology. 1995; 136(1):32-43. doi: 10.1006/exnr.1995.1081 PMID: 7589332.